Methotrexate is a high-risk drug, i.e. serious patient harm can occur as a result of errors involving incorrect frequency (daily rather once weekly), incorrect strength tablets, incorrect strength tablets, or from an adverse drug reaction. Care must be taken with methotrexate use at all stages of medication use, including at transitions of care. Click here to view IMSN’s Safety Alert on the Use of Once Weekly Oral Methotrexate
Recent Posts
- Ground-breaking All-Island Medication Safety Conference to Take Place Amidst Rising Healthcare Challenges 29 November 2024
- Parkinson’s disease: Reducing harm from medications (Safety Alerts) 11 November 2024
- Sound Alike Look Alike Drugs (SALADs) 5 November 2024
- Safe Use of Intravenous Iron 22 October 2024
- Safe use of Oxytocin 17 June 2024
Trackbacks/Pingbacks